2-(1H-benzimidazol-2-yl)benzo[f]chromen-3-imine;3-(1H-benzimidazol-2-yl)chromen-2-one;3-(1H-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one;[3-(1H-benzimidazol-2-yl)-2-iminochromen-7-yl]methanol;3-(1,3-benzothiazol-2-yl)-7-(diethylamino)chromen-2-one

C93H73N13O9S — CID 159538083

IUPAC2-(1H-benzimidazol-2-yl)benzo[f]chromen-3-imine;3-(1H-benzimidazol-2-yl)chromen-2-one;3-(1H-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one;[3-(1H-benzimidazol-2-yl)-2-iminochromen-7-yl]methanol;3-(1,3-benzothiazol-2-yl)-7-(diethylamino)chromen-2-one
SMILESCCN(CC)c1ccc2cc(-c3nc4ccccc4[nH]3)c(=O)oc2c1.CCN(CC)c1ccc2cc(-c3nc4ccccc4s3)c(=O)oc2c1.O=c1oc2ccccc2cc1-c1nc2ccccc2[nH]1.[H]/N=c1\oc2cc(CO)ccc2cc1-c1nc2ccccc2[nH]1.[H]/N=c1\oc2ccc3ccccc3c2cc1-c1nc2ccccc2[nH]1
InChIInChI=1S/C20H19N3O2.C20H13N3O.C20H18N2O2S.C17H13N3O2.C16H10N2O2/c1-3-23(4-2)14-10-9-13-11-15(20(24)25-18(13)12-14)19-21-16-7-5-6-8-17(16)22-19;21-19-15(20-22-16-7-3-4-8-17(16)23-20)11-14-13-6-2-1-5-12(13)9-10-18(14)24-19;1-3-22(4-2)14-10-9-13-11-15(20(23)24-17(13)12-14)19-21-16-7-5-6-8-18(16)25-19;18-16-12(17-19-13-3-1-2-4-14(13)20-17)8-11-6-5-10(9-21)7-15(11)22-16;19-16-11(9-10-5-1-4-8-14(10)20-16)15-17-12-6-2-3-7-13(12)18-15/h5-12H,3-4H2,1-2H3,(H,21,22);1-11,21H,(H,22,23);5-12H,3-4H2,1-2H3;1-8,18,21H,9H2,(H,19,20);1-9H,(H,17,18)/b;21-19-;;18-16-;
InChIKeyMDVTXKLETFKCAN-AYRXWQGPSA-N
MW1548.76 g/mol
LogP19.99
Rot. Bonds12

About 2-(1H-benzimidazol-2-yl)benzo[f]chromen-3-imine;3-(1H-benzimidazol-2-yl)chromen-2-one;3-(1H-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one;[3-(1H-benzimidazol-2-yl)-2-iminochromen-7-yl]methanol;3-(1,3-benzothiazol-2-yl)-7-(diethylamino)chromen-2-one

2-(1H-benzimidazol-2-yl)benzo[f]chromen-3-imine;3-(1H-benzimidazol-2-yl)chromen-2-one;3-(1H-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one;[3-(1H-benzimidazol-2-yl)-2-iminochromen-7-yl]methanol;3-(1,3-benzothiazol-2-yl)-7-(diethylamino)chromen-2-one (PubChem CID 159538083) has the molecular formula C93H73N13O9S and a molecular weight of 1548.76 g/mol. Its IUPAC name is 2-(1H-benzimidazol-2-yl)benzo[f]chromen-3-imine;3-(1H-benzimidazol-2-yl)chromen-2-one;3-(1H-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one;[3-(1H-benzimidazol-2-yl)-2-iminochromen-7-yl]methanol;3-(1,3-benzothiazol-2-yl)-7-(diethylamino)chromen-2-one.

Molecular Properties

Compound Name2-(1H-benzimidazol-2-yl)benzo[f]chromen-3-imine;3-(1H-benzimidazol-2-yl)chromen-2-one;3-(1H-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one;[3-(1H-benzimidazol-2-yl)-2-iminochromen-7-yl]methanol;3-(1,3-benzothiazol-2-yl)-7-(diethylamino)chromen-2-one
PubChem CID159538083
Molecular FormulaC93H73N13O9S
Molecular Weight1548.76 g/mol
Exact Mass1547.54
IUPAC Name2-(1H-benzimidazol-2-yl)benzo[f]chromen-3-imine;3-(1H-benzimidazol-2-yl)chromen-2-one;3-(1H-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one;[3-(1H-benzimidazol-2-yl)-2-iminochromen-7-yl]methanol;3-(1,3-benzothiazol-2-yl)-7-(diethylamino)chromen-2-one
SMILESCCN(CC)c1ccc2cc(-c3nc4ccccc4[nH]3)c(=O)oc2c1.CCN(CC)c1ccc2cc(-c3nc4ccccc4s3)c(=O)oc2c1.O=c1oc2ccccc2cc1-c1nc2ccccc2[nH]1.[H]/N=c1\oc2cc(CO)ccc2cc1-c1nc2ccccc2[nH]1.[H]/N=c1\oc2ccc3ccccc3c2cc1-c1nc2ccccc2[nH]1
InChIInChI=1S/C20H19N3O2.C20H13N3O.C20H18N2O2S.C17H13N3O2.C16H10N2O2/c1-3-23(4-2)14-10-9-13-11-15(20(24)25-18(13)12-14)19-21-16-7-5-6-8-17(16)22-19;21-19-15(20-22-16-7-3-4-8-17(16)23-20)11-14-13-6-2-1-5-12(13)9-10-18(14)24-19;1-3-22(4-2)14-10-9-13-11-15(20(23)24-17(13)12-14)19-21-16-7-5-6-8-18(16)25-19;18-16-12(17-19-13-3-1-2-4-14(13)20-17)8-11-6-5-10(9-21)7-15(11)22-16;19-16-11(9-10-5-1-4-8-14(10)20-16)15-17-12-6-2-3-7-13(12)18-15/h5-12H,3-4H2,1-2H3,(H,21,22);1-11,21H,(H,22,23);5-12H,3-4H2,1-2H3;1-8,18,21H,9H2,(H,19,20);1-9H,(H,17,18)/b;21-19-;;18-16-;
InChIKeyMDVTXKLETFKCAN-AYRXWQGPSA-N
XLogP19.99
TPSA318.93 Ų
H-Bond Donors7
H-Bond Acceptors19
Rotatable Bonds12
Heavy Atoms116
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001548.76
LogP ≤ 519.99
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1019

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'cumarine', 'substructure': 'N/A'}, {'alert_name': 'Polycyclic_aromatic_hydrocarbon_3', 'substructure': 'N/A'}

Analyze 2-(1H-benzimidazol-2-yl)benzo[f]chromen-3-imine;3-(1H-benzimidazol-2-yl)chromen-2-one;3-(1H-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one;[3-(1H-benzimidazol-2-yl)-2-iminochromen-7-yl]methanol;3-(1,3-benzothiazol-2-yl)-7-(diethylamino)chromen-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-(1H-benzimidazol-2-yl)benzo[f]chromen-3-imine;3-(1H-benzimidazol-2-yl)chromen-2-one;3-(1H-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one;[3-(1H-benzimidazol-2-yl)-2-iminochromen-7-yl]methanol;3-(1,3-benzothiazol-2-yl)-7-(diethylamino)chromen-2-one?
The IUPAC name of 2-(1H-benzimidazol-2-yl)benzo[f]chromen-3-imine;3-(1H-benzimidazol-2-yl)chromen-2-one;3-(1H-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one;[3-(1H-benzimidazol-2-yl)-2-iminochromen-7-yl]methanol;3-(1,3-benzothiazol-2-yl)-7-(diethylamino)chromen-2-one (CID 159538083) is 2-(1H-benzimidazol-2-yl)benzo[f]chromen-3-imine;3-(1H-benzimidazol-2-yl)chromen-2-one;3-(1H-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one;[3-(1H-benzimidazol-2-yl)-2-iminochromen-7-yl]methanol;3-(1,3-benzothiazol-2-yl)-7-(diethylamino)chromen-2-one.
What is the SMILES notation for 2-(1H-benzimidazol-2-yl)benzo[f]chromen-3-imine;3-(1H-benzimidazol-2-yl)chromen-2-one;3-(1H-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one;[3-(1H-benzimidazol-2-yl)-2-iminochromen-7-yl]methanol;3-(1,3-benzothiazol-2-yl)-7-(diethylamino)chromen-2-one?
The canonical SMILES for 2-(1H-benzimidazol-2-yl)benzo[f]chromen-3-imine;3-(1H-benzimidazol-2-yl)chromen-2-one;3-(1H-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one;[3-(1H-benzimidazol-2-yl)-2-iminochromen-7-yl]methanol;3-(1,3-benzothiazol-2-yl)-7-(diethylamino)chromen-2-one is CCN(CC)c1ccc2cc(-c3nc4ccccc4[nH]3)c(=O)oc2c1.CCN(CC)c1ccc2cc(-c3nc4ccccc4s3)c(=O)oc2c1.O=c1oc2ccccc2cc1-c1nc2ccccc2[nH]1.[H]/N=c1\oc2cc(CO)ccc2cc1-c1nc2ccccc2[nH]1.[H]/N=c1\oc2ccc3ccccc3c2cc1-c1nc2ccccc2[nH]1.
What is the InChIKey of 2-(1H-benzimidazol-2-yl)benzo[f]chromen-3-imine;3-(1H-benzimidazol-2-yl)chromen-2-one;3-(1H-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one;[3-(1H-benzimidazol-2-yl)-2-iminochromen-7-yl]methanol;3-(1,3-benzothiazol-2-yl)-7-(diethylamino)chromen-2-one?
The InChIKey is MDVTXKLETFKCAN-AYRXWQGPSA-N. The full InChI is InChI=1S/C20H19N3O2.C20H13N3O.C20H18N2O2S.C17H13N3O2.C16H10N2O2/c1-3-23(4-2)14-10-9-13-11-15(20(24)25-18(13)12-14)19-21-16-7-5-6-8-17(16)22-19;21-19-15(20-22-16-7-3-4-8-17(16)23-20)11-14-13-6-2-1-5-12(13)9-10-18(14)24-19;1-3-22(4-2)14-10-9-13-11-15(20(23)24-17(13)12-14)19-21-16-7-5-6-8-18(16)25-19;18-16-12(17-19-13-3-1-2-4-14(13)20-17)8-11-6-5-10(9-21)7-15(11)22-16;19-16-11(9-10-5-1-4-8-14(10)20-16)15-17-12-6-2-3-7-13(12)18-15/h5-12H,3-4H2,1-2H3,(H,21,22);1-11,21H,(H,22,23);5-12H,3-4H2,1-2H3;1-8,18,21H,9H2,(H,19,20);1-9H,(H,17,18)/b;21-19-;;18-16-;.
What are the key properties of 2-(1H-benzimidazol-2-yl)benzo[f]chromen-3-imine;3-(1H-benzimidazol-2-yl)chromen-2-one;3-(1H-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one;[3-(1H-benzimidazol-2-yl)-2-iminochromen-7-yl]methanol;3-(1,3-benzothiazol-2-yl)-7-(diethylamino)chromen-2-one?
2-(1H-benzimidazol-2-yl)benzo[f]chromen-3-imine;3-(1H-benzimidazol-2-yl)chromen-2-one;3-(1H-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one;[3-(1H-benzimidazol-2-yl)-2-iminochromen-7-yl]methanol;3-(1,3-benzothiazol-2-yl)-7-(diethylamino)chromen-2-one has a molecular weight of 1548.76 g/mol, XLogP of 19.99, 12 rotatable bonds, 7 hydrogen bond donors, and 19 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(1H-benzimidazol-2-yl)benzo[f]chromen-3-imine;3-(1H-benzimidazol-2-yl)chromen-2-one;3-(1H-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one;[3-(1H-benzimidazol-2-yl)-2-iminochromen-7-yl]methanol;3-(1,3-benzothiazol-2-yl)-7-(diethylamino)chromen-2-one is sourced from PubChem (CID 159538083), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).